Navigation Links
Details of HER-2/neu Class I Antigen Licensed by TapImmune published in Journal of Immunology: Antigen is a naturally processed epitope for breast cancer vaccines.
Date:1/22/2013

SEATTLE, Jan. 22, 2013 /PRNewswire/ -- TapImmune Inc. (OTCBB: TPIV) is pleased to announce the January publication of a paper titled "Enzymatic Discovery of a HER-2/neu Epitope That Generates Cross-Reactive T-cells", authored by Henle et al, J.Immunol. (2013), 190, 479-488.  This work, performed in the laboratory of Dr Keith Knutson at Mayo Clinic, describes the discovery of a novel HER-2/neu Class I epitope (p373-382) TapImmune has licensed from Mayo Clinic for the development of breast cancer vaccines.  The significance of this work is that this newly discovered antigen is a naturally occurring antigen processed by the proteasome and elicits peptide-specific T-cell responses.  This results in stronger binding to HLA-A2 and more efficient killing of HER-2/neu positive breast cancer cells by activated T-cells compared to the Class I epitope, p369-377 (E75) which was not naturally processed by the proteasome.

"These results provide an explanation of the molecular immunology behind our approach to HER-2/neu immunotherapy," said Mark Reddish Vice President of TapImmune Inc.  "These data describe how the HER-2/neu protein is processed by the proteasome to then be presented for immune recognition and killing.  By revealing the true identity of the immunodominant epitope responsible for class I mediated killing of HER-2/neu positive tumors, it is now possible to generate a true second generation vaccine that incorporates the correct target as it naturally appears on human tumors.  For nearly 20 years the immunology of this key protein has been clouded by contradictory observations, and these data finally provide an understanding of the 'natural target' displayed on human tumors. We expect to combine this immunodominant peptide with our broadly reactive helper peptides that are currently being tested in a phase I trial, to create a tru
'/>"/>

SOURCE TapImmune Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Report Details NCPA Efforts to Drive Greater Medication Adherence
2. ADVENTRX Announces Details Of The Phase 3 Study Of ANX-188
3. CoLucid Pharmaceuticals Details Phase 3 Development Strategy for Lasmiditan to Address Major Unmet Needs in Acute Migraine Therapy
4. Young Innovations, Inc. Provides 2nd Quarter Conference Call Details
5. CryoLife Announces Release Date and Teleconference Call Details for 2012 Second Quarter Financial Results
6. Physician Details Problems with Medicare Approval Process for Power Wheelchairs
7. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
8. Robbins Arroyo LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Hemispherx Biopharma, Inc.
9. MAQUET Cardiovascular Announces U.S. Food and Drug Administration Panel Votes To Reclassify Intra-Aortic Balloon Pumps To A Class II Designation In Certain Indications
10. Barrack, Rodos & Bacine Files Class Action Lawsuit Against St. Jude Medical, Inc.
11. Thomson Reuters Empowers Drug Development and Clinical Professionals to Develop Better, Faster Clinical Trials with Best-in-Class Intelligence Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 Decision Resources ... in the EU5 countries ( France , ... , Spain and the ... view of the first once-daily long-acting beta2 agonist/inhaled corticosteroid ... robust uptake of Relvar as a first-line LABA/ICS FDC ...
(Date:7/24/2014)... BOSTON , July 24, 2014 Boston ... on Tomorrow (#PedInno14), will feature an "Innovation Tank" ... innovators an opportunity to pitch their business or product ... of funding and feedback on how to accelerate the ... competition, occurring the morning of Friday, October 31, will ...
(Date:7/24/2014)... IRVING, Texas , July 24, 2014 /PRNewswire/ ... in the cardiovascular market that could impact patient ... Spring 2014 CV Watch , "Innovations in ... report provides hospitals with guidance and details on ... serve patient needs and understand how these options ...
Breaking Medicine Technology:Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 2Surveyed EU5 Pulmonologists Expect that Relvar, the First Once-Daily LABA/ICS FDC, Will Experience Healthy Uptake in Asthma 3Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 2Taking on Tomorrow to Feature "Innovation Tank" Pitch Opportunity for Aspiring Pediatric Health Care Entrepreneurs 3New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 2New Novation CV Watch Shows Recent Technology Innovations Could Drive Cardiovascular Product Costs Up by as Much as 35 Percent 3
... 16 The following is being,issued by Trust ... call to discuss a new report from the,American ... Health (TFAH),"Pandemic Influenza: Warning, Children At-Risk." The report ... for children during a possible,pandemic flu outbreak and ...
... Oct. 16 Boston Scientific,Corporation (NYSE: ... the Company,s major,events and press announcements at ... Cardiovascular Therapeutics (TCT),scientific symposium, which runs from ... Boston Scientific will be announcing a ...
Cached Medicine Technology:Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 2Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 3Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 4Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 5Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 6Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007 7
(Date:7/24/2014)... semen is naturally colonized by bacteria, and a new study ... both HIV transmission and levels in infected men. U.S. ... play a role in local inflammation and in the production ... to possible targets for reducing transmission of the AIDS-causing virus. ... changes in HIV levels, and the researchers say more research ...
(Date:7/24/2014)... the body,s own immune system play a role in ... chronic epilepsy, Alzheimer,s dementia and concussions? Cleveland Clinic researchers ... PLOS ONE . , The study focuses on ... serves as a biomarker for brain damage. Normally, S100B ... However, following a brain injury, it can leak through ...
(Date:7/24/2014)... to transform into an aggressive form of cancer, are ... the metastasis or, even better, prevent their formation would ... Researchers at Universit catholique de Louvain (Belgium) successfully performed ... mice. The results of their study are published ... Cell Reports . , The work by Professor Pierre ...
(Date:7/24/2014)... prenatal ultrasounds uncover antenatal hydronephrosis, or enlarged kidneys, ... United States. Many children with this abnormality are ... few years of life with the hopes of ... recently, however, little evidence existed as to the ... and inconvenience for families. But a study published ...
(Date:7/24/2014)... The Biofeedback Federation of Europe is ... game development company Zukor Interactive. The agreement provides ... Zukor's Grind , a next-generation feedback game ... and international markets. , Zukor's Grind is a ... as a biofeedback/neurofeedback training tool. Typical training provides ...
Breaking Medicine News(10 mins):Health News:Bacteria in Semen May Affect HIV Transmission, Levels: Study 2Health News:Immune response may cause harm in brain injuries, disorders 2Health News:A world first: Researchers identify a treatment that prevents tumor metastasis 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 2Health News:Continuous antibiotics not necessary for many children with common prenatal abnormality 3Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 2Health News:Biofeedback Federation of Europe Enters Distribution Agreement with Zukor Interactive 3
... chromosome lineage reveals farming influence , TUESDAY, Jan. 19 (HealthDay ... farmers who migrated from the Near East 10,000 years ago, ... Y chromosome, which is passed from father to son. , ... by about 110 million men -- it follows a gradient ...
... A.M. , Justin Herman Plaza , Market ... www.walkforlifewc.c o m , Speakers and organizers are available ... A woman who walked away from her job as a clinic director at ... on exposing abuses in the abortion industry will speak at the 6th Annual Walk ...
... , MIDLAND, ... adopt lifelong healthy behaviors with Health Enhancement Systems, ( ... The online program, 5 on 5 ( www.5on5.com ... habits wrapped in an exciting basketball tournament format. Participants form teams of ...
... , STRATHAM, N.H. ... world,s leading producer of premium chocolate, announces it is accepting nominations for ... the second year, Lindt will honor ordinary individuals who are extraordinary champions ... Lindt Unsung Heroes of Autism program is part of Lindt,s partnership with ...
... ,greater than, problems, study suggests , TUESDAY, Jan. 19 ... math? , A German team of neurobiologists has found ... using specific brain cells dedicated to the comprehension of ... insight into the neurology behind human ability to comprehend ...
... , TAMPA, Fla. , Jan. 19 ... Preventative Task Force (USPTF), the Obesity Action Coalition (OAC) is ... coverage of the recommended childhood obesity treatments. , The recommendations ... in moderate to intensive programs helps children affected by obesity ...
Cached Medicine News:Health News:6th Annual Walk for Life West Coast Saturday, January 23, 2010 2Health News:Corporate Teams Score Points for Healthy Eating 2Health News:Corporate Teams Score Points for Healthy Eating 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 2Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 3Health News:Autism Speaks and Lindt Seeking Nominations for 'Lindt Unsung Heroes of Autism' 4Health News:Monkey Brain 'Hardwired' for Simple Math 2Health News:Monkey Brain 'Hardwired' for Simple Math 3Health News:Obesity Action Coalition Calls on Insurers and Employers to Increase Access to Childhood Obesity Treatments Based on Recent United States Preventative Task Force Recommendations 2
Gently curved shaft with blunt angled tip is ideal for chopping the lens during anterior chamber phacoemulsification....
Nucleus divider with 1.25 mm tip and blade offset at a 60 degree angle is ideal for performing the "Phaco Chop" technique to be used in left hand. Round knurled handle....
Flat 7 mm wide hook. Flat serrated handle with polished finish. Overall length: 5.1 inches....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
Medicine Products: